Chronoimmunology is a field of study that explores the intricate relationship between the immune system and circadian rhythms, which are daily fluctuations in biological processes tied to the 24-hour day-night cycle. The immune system exhibits a rhythmic pattern of activity, impacting various immune processes such as the production of cytokines, immune cell activity, and susceptibility to infections. Circadian rhythms influence the functioning of immune cells, including T cells, B cells, and macrophages, as well as the release of immune-modulating substances. Disruptions to circadian rhythms, such as those caused by shift work, irregular sleep patterns, or jet lag, can adversely affect immune function. Research in chronoimmunology has implications for understanding how the timing of interventions, such as vaccinations or drug administration, can optimize immune responses. The circadian regulation of immune processes is intricately connected to the overall health of an individual and may contribute to variations in disease susceptibility and severity at different times of the day. A comprehensive understanding of chronoimmunology has the potential to inform personalized medicine approaches, improve vaccine efficacy, and enhance strategies for managing immune-related disorders.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States